Furthermore, IL-17 is expressed in synovial sublining of RA patients (59) and inhibits collagen synthesis and bone formation in synovium and bone explants of RA patients (60).
The function of TLR4 upstream of IL-1 and IL-17 might have important consequences for the treatment of RA.